Advestra advised life sciences startup EvlaBio on its EUR 21 million seed financing round. Headquartered in Zurich, EvlaBio specialises in the development of therapies for Left Ventricular Hypertrophy (LVH) in the context of Chronic Kidney Disease (
Advestra advised life sciences startup EvlaBio on its EUR 21 million seed financing round. Headquartered in Zurich, EvlaBio specialises in the development of therapies for Left Ventricular Hypertrophy (LVH) in the context of Chronic Kidney Disease (